The DOI matches its Crossref record.
Pradimicin, a novel class of potent antifungal antibiotics.
Open accessAbstract
In the course of screening for new antibiotics active against fungi, an actinomycete strain No. PI57-2 that had been isolated from a soil sample collected in Fiji Island was found to produce novel antibiotics, pradimicins A and B1*^.Pradimicin A, the major component showed moderate in vitro activity against a wide variety of fungi and yeasts including clinically important pathogens.More interestingly, it exhibited marked in vivo therapeutic activity against systemic fungal infections caused by Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans strains in mice.Degradation studies revealed that pradimicin A has a unique structure containing the following moieties : D-Alanine, D-xylose, 4 ,6-dideoxy-4-methylamino-D-galactose and a substituted 5,6-dihydrobenzo[a]naphthacenequinone.This communicationpresents production, isolation, chemical and biological properties and structures of pradimicins A and B.Based on the taxonomic studies performed, strain PI57-2 is classified as a heretofore undescribed species of the genus Actinomaduraand named Actinomadurahibisca sp.nov.(ATCC 53557), and the details will be reported in a separate pap er.Pradimicin was produced in a 200-liter tank fermentor using a mediumconsisting of glucose 3%, soybean meal 3%, Pharmamedia 0.5%, yeast extract 0.1 % and CaCO3 0.3%.The tank was operated at 28°C with agitation of 250 rpm and aeration of 120 liters/minute.Antibiotic production was monitored by bioassay using C, albicans A9540 as a test organism and visible absorption at 500 nm in 0.01 n NaOH -MeOH (1 :1).After 5~6 days of fermentation, antibiotic potency reached the maximum of 500~700 /*g/ml.The harvested broth (108 liters) was centrifuged and the supernate was acidified to pH 2.0.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Metarhizium spp., Cosmopolitan Insect-Pathogenic Fungi: Mycological Aspects
Roberts, D. W., & St. Leger, R. J. (2004) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(04)54001-7 · Cited by 475
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
Balzarini, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1707 · Cited by 283
Antifungal Resistance Trends Towards the Year 2000: Implications for Therapy and New Approaches
Alexander, B. D., & Perfect, J. R. (1997) · Drugs · doi:10.2165/00003495-199754050-00002 · Cited by 153
Metadata
- Authors
- OKI, T., KONISHI, M., TOMATSU, K., TOMITA, K., SAITOH, K.-I., TSUNAKAWA, M., NISHIO, M., MIYAKI, T., & KAWAGUCHI, H.
- Venue
- The Journal of Antibiotics
- Published
- 1988
- Volume
- 41
- Issue
- 11
- Pages
- 1701-1704
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2020213057
- Cited by
- 186
- References
- 0
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pradimicin, a novel class of potent antifungal antibiotics. https://app.cochat.ai/papers/10.7164/antibiotics.41.1701
- The paper
- OKI, T., KONISHI, M., TOMATSU, K., TOMITA, K., SAITOH, K.-I., TSUNAKAWA, M., NISHIO, M., MIYAKI, T., & KAWAGUCHI, H. (1988). Pradimicin, a novel class of potent antifungal antibiotics. The Journal of Antibiotics. https://doi.org/10.7164/antibiotics.41.1701
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.